Based on the NSCLC cohort of TCGA, three of the 11 genes, namely CD79B, NDUFAB1, TRAF3IP3 exhibited significantly divergent survival patterns across the high and low-risk groups (Figure S2). This evidence concerns the gene NDUFAB1 and non-small cell lung carcinoma.